Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of quadrivalent split-virion influenza vaccine in children aged 6-35 months
CTR20233331Phase 3Suspended
- Sponsor
- Dalian Yalifeng Biopharmaceutical
- Start
- Oct 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza vaccine in influenza, sponsored by Dalian Yalifeng Biopharmaceutical. Started Oct 2023; status: suspended.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20233331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233331.